Wenfei Chen
Impact in
- Biotechnology top 1%
- Cancer Research and Treatments
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 10
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Zhirong Zhang (10 shared papers)Xun Sun (8 shared papers)Ming Qin (4 shared papers)Xun Sun (5 shared papers)Yining Zhu (9 shared papers)Hao Jiang (2 shared papers)Zhen Gu (1 shared paper)Xudong Zhang (1 shared paper)
- Journals
- Journal of Controlled Release (4 papers)Biomaterials (3 papers)Advanced Functional Materials (2 papers)ACS Nano (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wenfei Chen
36 papers receiving 1.6k citations
Wenfei Chen's Hit Papers
Peers
Comparison fields: 5 of 119
- Biotechnology 363
- Biomaterials 278
- Biomedical Engineering 794
- Immunology 294
- Pharmaceutical Science 75
Countries citing papers authored by Wenfei Chen
This map shows the geographic impact of Wenfei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfei Chen more than expected).
Fields of papers citing papers by Wenfei Chen
This network shows the impact of papers produced by Wenfei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfei Chen. The network helps show where Wenfei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenfei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy Hit paper breakdown → | 2018 | 333 |
| 2 | 2017 | 186 | |
| 3 | 2016 | 183 | |
| 4 | 2018 | 137 | |
| 5 | 2019 | 112 | |
| 6 | 2020 | 85 | |
| 7 | 2014 | 68 | |
| 8 | 2022 | 53 | |
| 9 | 2021 | 51 | |
| 10 | 2022 | 51 | |
| 11 | 2021 | 41 | |
| 12 | 2023 | 39 | |
| 13 | 2023 | 31 | |
| 14 | 2018 | 24 | |
| 15 | 2022 | 22 | |
| 16 | 2020 | 20 | |
| 17 | 2022 | 18 | |
| 18 | 2023 | 18 | |
| 19 | 2024 | 13 | |
| 20 | 1999 | 13 |
About Wenfei Chen
Wenfei Chen is a scholar working on Biomedical Engineering, Molecular Biology, Immunology, Biotechnology and Cancer Research, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Immunotherapy and Immune Responses (9 papers), Cancer Research and Treatments (7 papers), RNA Interference and Gene Delivery (4 papers), Virus-based gene therapy research (3 papers), Advanced Vision and Imaging (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Biotechnology (363 citations), Biomaterials (278 citations), Biomedical Engineering (794 citations), Immunology (294 citations) and Pharmaceutical Science (75 citations). Wenfei Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhirong Zhang, Xun Sun, Ming Qin, Xun Sun, Yining Zhu, Hao Jiang, Zhen Gu, Xudong Zhang, Ying Wang and Zhaofei Guo. Their work appears in journals such as Journal of Controlled Release, Biomaterials, Advanced Functional Materials, ACS Nano and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.